Download from app store
We have detected that you are using an Ad Blocker.
PracticeUpdate is free to end users but we rely on advertising to fund our site. Please consider supporting PracticeUpdate by whitelisting us in your ad blocker.
We have sent a message to the email address you have provided, . If this email is not correct, please update your settings with your correct address.
The email address you provided during registration, , does not appear to be valid. Please update your settings with a valid address before to continue using PracticeUpdate.
Please provide your AHPRA Number to ensure that you are given the correct level of access to our site.
featured

Expert Opinion / Cases · November 21, 2016

New Hormone Receptor Positive Breast Cancer While on Endocrine Therapy

 

Discuss This item Follow

No comments yet, be the first to start the discussion!

  • Comment deleted by Moderator.
  • Comment deleted by Moderator.
  • Comment deleted by Moderator.
  • Beata Kania-Zembaczyńska

    Nov 25, 2016

    New hormone positive breast cancer
    Mastectomy with slnd,and hormonotherapy -tamoxifen

  • Guy Lesec

    Nov 26, 2016

    The phenotype is close to the previous one, but we do not know if the grade is different and whether it is a luminal A or B. (KI 67?). However, recurrences are often more evolutive (3 cm): therefore, it is necessary to propose a total matectomy with axillary dissection, with the aid of a colored and radioactive tracer, but completing by a wider dissection given the cicatrational state of the lymphatic path. The other decisions depend on the new staging. A new-generation hormone therapy is in any case indicated

  • nagib khoury

    Nov 26, 2016

    most probably a new breast cancer,developped in a different quandrant..if us of the axilla is negative consider total mastectomy because of the size of the tumor.Breast irradiation can be added . post op palbociclib and fulvestrant is one option 

  • Nguyen Minh Tinh

    Nov 27, 2016

    I think this is recurrent Breast Cancer
    I recomment surgical for breast not axilla LND
    May be adjuvant RT 
    Systemic thẻapy: chemo follow Hormon

  • Oda Abushaban

    Dec 25, 2016

    This is recurrence B C need for MRM with axilla ,adjuvant RT and Tomoxfen +follow up

  • pramod kumar julka

    Feb 08, 2017

    it is new breast cancer  Mastectomy with sentinal lymph node dissection .genetic assay oncotype dx or endopredict may be done if low risk  PALBOCICLIB &FULVUSTRANT MAY BE GIVEN OTHERWISE CHEMOTHERAPY

  • Juan Rodriguez Agostini

    Feb 09, 2017

    I think it is a reccurrence from initial tumor. The therapeutic option is total mastectomy + SLNB (re-mapping) + Axillary clearance if SLN is positive. Radiation may be omitted if we do a total mastectomy. Systemic treatment: hormonal therapy with another AI (exemestane for example)

  • mouna kairouani

    Feb 19, 2017

    I think it is a recurrent breast cancer. I propose mastectomy with axillary dissection. The patient has already received radiotherapy. This is a secondary endocrine resistance with a relapse on the third year of hormone therapy. It is important to precise the ki 67 and score of oncotype dx for decision

  • Muhammad Jawaid Akhter Malick

    May 26, 2018

    In my opinion this is recurrent disease. Mastectomy +Ald. Then my look for recurrence score. Manage according to the recurrence rate, second line hormone therapy + xrt to axila + sup.clav. If high risk then chemotherapy followed by above.

  • pramod kumar julka

    May 28, 2018

    This is a new lesion. This may be treated by breast conservation surgery and put on hormones.

  • pramod kumar julka

    May 28, 2018

    This is a new lesion. This may be treated by breast conservation surgery and put on hormones.

  • Dec 23, 2024

    Pending Moderator approval.
    Delete

Further Reading